Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7

This publication has 42 references indexed in Scilit:

• The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
  European Journal of Cancer, 2010
• Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma
  British Journal of Cancer, 2010
• Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy
  Clinical Cancer Research, 2010
• Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
  Arthritis Research & Therapy, 2009
• Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
  Blood, 2009
• The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
  Cancer Research, 2007
• Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems
  Biotechnology Letters, 2007
• IL-7 Administration to Humans Leads to Expansion of CD8+ and CD4+ Cells but a Relative Decrease of CD4+ T-Regulatory Cells
  Journal of Immunotherapy, 2006
• Engineered vascular‐targeting antibody‐interferon‐γ fusion protein for cancer therapy
  International Journal of Cancer, 2005
• Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor Eradication
  Human Gene Therapy, 2000